MARC SCHEGERIN - 15 Jun 2021 Form 4 Insider Report for SQZ Biotechnologies Co

Role
Director
Signature
/s/ Lawrence Knopf, Attorney-in-Fact for Marc Schegerin
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 17:16:37 UTC
Next filing
15 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +10,500 $0.000000 10,500 15 Jun 2021 Common Stock 10,500 $13.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) June 15, 2022 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders following the date of grant, in each case subject to the Reporting Person's continued service on the Board.